Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Center Laboratories Inc

4123.TWO ✓ COMPLIANTFree checks used up today ☆ Track — members

Gretai Securities Market · Healthcare · Pharmaceuticals ·

Taiwan Small Cap Analyst: N/A

Last Close

$0.86

▼ -1.06%

Market Cap $695.93M · Vol 1.41M

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

100.94

FWD: N/A

Market Cap

$695.93M

Small Cap

Div Yield

5.86%

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

4.11

Momentum

Beta

0.18

vs Market

52W High

$1.50

43.27% below

52W Low

$0.85

1.43% above

Volume

1.41M

Avg 1.06M

P/B

1.17

Price-to-book

ROE

46.87%

Return on equity

Free Float

74.02%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Center Laboratories Inc (4123.TWO) stock is Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does 4123.TWO pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-5.70%

-9.94%

-23.37%

-24.35%

YTD

-29.08%

-16.42%

-32.56%

-41.37%

Financials & Valuation

TTM · Annual

Total Revenue	$48.39M
Net Income	$297.54M
Revenue Growth (YoY)	+14.09%
Gross Margin	40.97%
Operating Margin	-23.85%
Net Profit Margin	614.89%
ROE	46.87%
ROA · ROIC	38.46% · 33.96%

P/E Ratio	100.94
Forward P/E (FY1)	N/A
PEG Ratio	0.00
P/S	22.55
P/B	1.17
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	807.46M

Technical Indicators

50-Day SMA	$0.94
200-Day SMA	$1.11
RSI (14)	4.11
Beta	0.18
52-Week High	$1.50
52-Week Low	$0.85

Volume Today	1.41M
Avg Daily Volume (30D)	1.06M
Relative Volume	1.33x
Volatility (10D)	16.38
Volatility (30D)	16.80
Free Float	74.02%

Analyst Consensus

N/A

Current Price $0.86

Mean Target N/A

52W Low$0.85 52W High$1.50

Current

Target

$0.85 $1.50

Current Analyst target

· 0 analysts

Identifiers

ExchangeGretai Securities Market

FIGIBBG001SKZWT2

ISINTW0004123005

CountryTaiwan

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Company -0.46% JNJ Johnson & Johnson -0.97% ABBV AbbVie Inc. -2.05% NVS Novartis AG +0.45% NOVN.S Novartis AG -1.69%

Company Profile

Center Laboratories Inc is a Taiwan-based company engaged in the development of pharmaceutical products. The Company's products mainly focus on internal liquids, including syrups, suspensions, liquids and other dosage forms. Pharmacological classifications include respiratory tract therapeutics such as cough suppressants, sputum expectorants, asthma medications, and runny nose relief, while antipyretic and analgesic medications and gastrointestinal medications are also in great demand, and a variety of internal liquids and lozenges for the treatment of central nervous system (CNS) such as epilepsy, dysphoria, dementia, and Parkinson's disease have already been introduced into the market. The Company is a specialized manufacturer of internal liquid.